Role of heme oxygenase-1 in postnatal differentiation of stem cells: A possible cross-talk with MicroRNAs

Antioxidants and Redox Signaling

Volumn 20, Issue 11, 2014, Pages 1827-1850

  Kozakowska, Magdalena ^a   Szade, Krzysztof ^a   Dulak, Jozef ^a   Jozkowicz, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; FERROUS ION; HEME OXYGENASE 1; MICRORNA; NEUROGENIC DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; UNTRANSLATED RNA;

ADIPOCYTE; ADIPOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL NUCLEUS; CELLS; ENZYME ACTIVITY; HEART MUSCLE CELL; HEMATOPOIETIC CELL; MOLECULAR INTERACTION; MUSCLE DEVELOPMENT; MYOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PERINATAL PERIOD; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEMATOPOIESIS; HEME OXYGENASE-1; HUMANS; MICRORNAS; NEOPLASMS; NEURAL STEM CELLS; OSTEOBLASTS; OSTEOCLASTS; SIGNAL TRANSDUCTION;

EID: 84896335478     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5341     Document Type: Review

References (256)

1. Abdallah BM and Kassem M. New factors controlling the balance between osteoblastogenesis and adipogenesis. Bone 50: 540-545, 2012.
2. Abraham NG. Molecular regulation-biological role of heme in hematopoiesis. Blood Rev 5: 19-28, 1991.
3. Afonyushkin T, Oskolkova OV, Philippova M, Resink TJ, Erne P, Binder BR, and Bochkov VN. Oxidized phospho-lipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arterioscler Thromb Vasc Biol 30: 1007-1013, 2010.
4. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K, Franzin C, Cortivo R, Rossato M, Vettor R, Abatangelo G, Pozzan T, Pinton P, and Rizzuto R. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA 105: 1226-1231, 2008.
5. Akimoto T, Ushida T, Miyaki S, Akaogi H, Tsuchiya K, Yan Z, Williams RS, and Tateishi T. Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signaling. Biochem Biophys Res Commun 329: 381-385, 2005.
6. Almeida M. Unraveling the role of FoxOs in bone-insights from mouse models. Bone 49: 319-327, 2011.
7. Alves LR, Costa ES, Sorgine MH, Nascimento-Silva MC, Teodosio C, Barcena P, Castro-Faria-Neto HC, Bozza PT, Orfao A, Oliveira PL, and Maya-Monteiro CM. Heme-oxygenases during erythropoiesis in K562 and human bone marrow cells. PLoS One 6: e21358, 2011.
8. Ambros V and Chen X. The regulation of genes and genomes by small RNAs. Development 134: 1635-1641, 2007.
9. Artaud-Macari E, Goven D, Brayer S, Hamimi A, Besnard V, Marchal-Somme J, Ali ZE, Crestani B, Kerdine-Romer S, Boutten A, and Bonay M. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic de-differentiation in idiopathic pulmonary fibrosis. Antioxid Redox Signal 18: 66-79, 2013.
10. Asahara T, Kawamoto A, and Masuda H. Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29: 1650-1655, 2011.
11. Asakura A, Komaki M, and Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68: 245-253, 2001.
12. Aziz A, Sebastian S, and Dilworth FJ. The origin and fate of muscle satellite cells. Stem Cell Rev 8: 609-622, 2012.
13. Barbagallo I, Tibullo D, Di Rosa M, Giallongo C, Palumbo GA, Raciti G, Campisi A, Vanella A, Green CJ, and Mot-terlini R. A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mes-enchymal stem cells. J Neurosci Res 86: 1927-1935, 2008.
14. Barbagallo I, Vanella A, Peterson SJ, Kim DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Rai-mondo FD, Abraham NG, and Asprinio D. Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Miner Metab 28: 276-288, 2009.
15. Barrera LN, Rushworth SA, Bowles KM, and MacEwan DJ. Bortezomib induces heme oxygenase-1 expression in multiple myeloma. Cell Cycle 11: 2248-2252, 2012.
16. Baruscotti I, Barchiesi F, Jackson EK, Imthurn B, Stiller R, Kim JH, Schaufelberger S, Rosselli M, Hughes CC, and Dubey RK. Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen re-ceptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine ki-nase. Hypertension 56: 397-404, 2010.
17. Beckman JD, Chen C, Nguyen J, Thayanithy V, Sub-ramanian S, Steer CJ, and Vercellotti GM. Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem 286: 3194-3202, 2011.
18. Bellin M, Marchetto MC, Gage FH, and Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 13: 713-726, 2012.
19. Berardi E, Pues M, Thorrez L, and Sampaolesi M. miRNAs in ESC differentiation. Am J Physiol Heart Circ Physiol 303: H931-H939, 2012.
20. Bessis M. [Erythroblastic island, functional unity of bone marrow]. Rev Hematol 13: 8-11, 1958 [Article in French].
21. Bianco P. Bone and the hematopoietic niche: a tale of two stem cells. Blood 117: 5281-5288, 2011.
22. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, and Wang CY. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19: 35-42, 2013.
23. Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, Mihailovic A, Choi YH, Tuschl T, and Bosio A. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133 + and CD34 + hemato-poietic stem and progenitor cells. Stem Cells 29: 847-857, 2011.
24. Boyle WJ, Simonet WS, and Lacey DL. Osteoclast differentiation and activation. Nature 423: 337-342, 2003.
25. Bryder D, Rossi DJ, and Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 169: 338-346, 2006.
26. Brzoska E, Ciemerych MA, Przewozniak M, and Zimowska M. Regulation of muscle stem cells activation: the role of growth factors and extracellular matrix. Vitam Horm 87: 239-276, 2011.
27. Burgess A, Li M, Vanella L, Kim DH, Rezzani R, Rodella L, Sodhi K, Canestraro M, Martasek P, Peterson SJ, Kappas A, and Abraham NG. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension 56: 1124-1130, 2010.
28. Camilleri S and McDonald F. Runx2 and dental development. Eur J Oral Sci 114: 361-373, 2006.
29. Cao J, Peterson SJ, Sodhi K, Vanella L, Barbagallo I, Rodella LF, Schwartzman ML, Abraham NG, and Kappas A. Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet. Hypertension 60: 467-475, 2012.
30. Cao YA, Kusy S, Luong R, Wong RJ, Stevenson DK, and Contag CH. Heme oxygenase-1 deletion affects stress erythropoiesis. PLoS One 6: e20634, 2011.
31. Cao YA, Wagers AJ, Karsunky H, Zhao H, Reeves R, Wong RJ, Stevenson DK, Weissman IL, and Contag CH. Heme oxygenase-1 deficiency leads to disrupted response to acute stress in stem cells and progenitors. Blood 112: 4494-4502, 2008.
32. Carrer M, Liu N, Grueter CE, Williams AH, Frisard MI, Hulver MW, Bassel-Duby R, and Olson EN. Control of mitochondrial metabolism and systemic energy homeo-stasis by microRNAs 378 and 378*. Proc Natl Acad Sci USA 109: 15330-15335, 2012.
33. Carriere A, Carmona MC, Fernandez Y, Rigoulet M, Wenger RH, Penicaud L, and Casteilla L. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 279: 40462-40469, 2004.
34. Chae HJ, Chin HY, Lee GY, Park HR, Yang SK, Chung HT, Pae HO, Kim HM, Chae SW, and Kim HR. Carbon monoxide and nitric oxide protect against tumor necrosis factor-alpha-induced apoptosis in osteoblasts: HO-1 is necessary to mediate the protection. Clin Chim Acta 365: 270-278, 2006.
35. Charge SB and Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238, 2004.
36. Chasis JA and Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 112: 470-478, 2008.
37. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, and Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233, 2006.
38. Choi J, Costa ML, Mermelstein CS, Chagas C, Holtzer S, and Holtzer H. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci USA 87: 7988-7992, 1990.
39. Chu CY, Chen CF, Rajendran RS, Shen CN, Chen TH, Yen CC, Chuang CK, Lin DS, and Hsiao CD. Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish. PLoS One 7: e36474, 2012.
40. Chung SS, Hu W, and Park CY. The role of microRNAs in hematopoietic stem cell and leukemic stem cell function. Ther Adv Hematol 2: 317-334, 2011.
41. Clerigues V, Guillen MI, Castejon MA, Gomar F, Mirabet V, and Alcaraz MJ. Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1beta in osteoarthritic os-teoblasts. Biochem Pharmacol 83: 395-405, 2012.
42. Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozko-wicz A, Dulak J. MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem 401: 2051-2061, 2011.
43. Clerigues V, Guillen MI, Gomar F, and Alcaraz MJ. Haem oxygenase-1 counteracts the effects of interleukin-1beta on inflammatory and senescence markers in cartilage-sub-chondral bone explants from osteoarthritic patients. Clin Sci (Lond) 122: 239-250, 2013.
44. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231-241, 2008.
45. Collino F, Bruno S, Deregibus MC, Tetta C, and Camussi G. MicroRNAs and mesenchymal stem cells. Vitam Horm 87: 291-320, 2011.
46. Collins CA. Satellite cell self-renewal. Curr Opin Pharmacol 6: 301-306, 2006.
47. Curtis HJ, Sibley CR, and Wood MJ. Mirtrons, an emerging class of atypical miRNA. Wiley Interdiscip Rev RNA 3: 617-632, 2012.
48. Curtis MA, Low VF, and Faull RL. Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation. Dev Neurobiol 72: 990-1005, 2012.
49. Dean M, Fojo T, and Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005.
50. Deng Z, Du WW, Fang L, Shan SW, Qian J, Lin J, Qian W, Ma J, Rutnam ZJ, and Yang BB. The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor. J Biol Chem 288: 319-331, 2013.
51. Denschlag D, Marculescu R, Unfried G, Hefler LA, Exner M, Hashemi A, Riener EK, Keck C, Tempfer CB, and Wagner O. The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod 10: 211-214, 2004.
52. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, and Agarwal A. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204: 605-618, 2007.
53. Faller M, Matsunaga M, Yin S, Loo JA, and Guo F. Heme is involved in microRNA processing. Nat Struct Mol Biol 14: 23-29, 2007.
54. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361, 2003.
55. Fischer-Posovszky P, Tews D, Horenburg S, Debatin KM, and Wabitsch M. Differential function of Akt1 and Akt2 in human adipocytes. Mol Cell Endocrinol 358: 135-143, 2012.
56. Fumimoto R, Sakai E, Yamaguchi Y, Sakamoto H, Fukuma Y, Nishishita K, Okamoto K, and Tsukuba T. The coffee diterpene kahweol prevents osteoclastogenesis via impairment of NFATc1 expression and blocking of Erk phos-phorylation. J Pharmacol Sci 118: 479-486, 2012.
57. Gagan J, Dey BK, Layer R, Yan Z, and Dutta A. MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J Biol Chem 286: 19431-19438, 2011.
58. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, and Falini B. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105: 3945-3950, 2008.
59. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, and MacDougald OA. Roles for miRNA-378/378* in adi-pocyte gene expression and lipogenesis. Am J Physiol En-docrinol Metab 299: E198-E206, 2010.
60. GimbleJM and Nuttall ME. Therelationship betweenadipose tissue and bone metabolism. Clin Biochem 45: 874-879, 2012.
61. Gorbunov N, Petrovski G, Gurusamy N, Ray D, Kim do H, and Das DK. Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells. J Cell Mol Med 16: 174-184, 2012.
62. Grochot-Przeczek A, Dulak J, and Jozkowicz A. Haem oxygenase-1: non-canonical roles in physiology and pathology. Clin Sci (Lond) 122: 93-103, 2012.
63. Gromak N. Intronic microRNAs: a crossroad in gene regulation. Biochem Soc Trans 40: 759-761, 2012.
64. Gu Q, Cai Y, Huang C, Shi Q, and Yang H. Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation. Pharmacogn Mag 8: 202-208, 2012.
65. Guillen M, Megias J, Gomar F, and Alcaraz M. Haem oxygenase-1 regulates catabolic and anabolic processes in osteoarthritic chondrocytes. J Pathol 214: 515-522, 2008.
66. Gurusamy N, Ray D, Lekli I, and Das DK. Red wine anti-oxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium. J Cell Mol Med 14: 2235-2239, 2010.
67. Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, and Lee ZH. Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301: 119-127, 2004.
68. Hama M, Kirino Y, Takeno M, Takase K, Miyazaki T, Yoshimi R, Ueda A, Itoh-Nakadai A, Muto A, Igarashi K, and Ishigatsubo Y. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways. Arthritis Rheum 64: 1518-1528, 2012.
69. Heasman SA, Zaitseva L, Bowles KM, Rushworth SA, and Macewan DJ. Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1. Oncotarget 2: 658-668, 2011.
70. Herrmann H, Kneidinger M, Cerny-Reiterer S, Rulicke T, Willmann M, Gleixner KV, Blatt K, Hormann G, Peter B, Samorapoompichit P, Pickl W, Bharate GY, Mayerhofer M, Sperr WR, Maeda H, and Valent P. The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38-AML progenitor cells. Curr Cancer Drug Targets 12: 51-63, 2012.
71. Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, and Yoneda Y. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 281: 18015-18024, 2006.
72. Hinoi E, Takarada T, Fujimori S, Wang L, Iemata M, Uno K, and Yoneda Y. Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis. Bone 40: 337-344, 2007.
73. Holst D, Luquet S, Kristiansen K, and Grimaldi PA. Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdifferentiation. Exp Cell Res 288: 168-176, 2003.
74. Hou W, Tian Q, Steuerwald NM, Schrum LW, and Bonkovsky HL. The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim Biophys Acta 1819: 1113-1122, 2012.
75. Hou W, Tian Q, Zheng J, and Bonkovsky HL. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 51: 1494-1504, 2010.
76. Hu R, Li H, Liu W, Yang L, Tan YF, and Luo XH. Targeting miRNAs in osteoblast differentiation and bone formation. Expert Opin Ther Targets 14: 1109-1120, 2010.
77. Ibrahim NG, Lutton JD, and Levere RD. The role of haem biosynthetic and degradative enzymes in erythroid colony development: the effect of haemin. Br J Haematol 50: 17-28, 1982.
78. Inose H, Ochi H, Kimura A, Fujita K, XuR, SatoS, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, Saito K, Nakamura T, Siomi H, Ito H, Arai Y, Shinomiya K, and Takeda S. A mi-croRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA 106: 20794-20799, 2009.
79. Itoigawa Y, Kishimoto KN, Okuno H, Sano H, Kaneko K, and Itoi E. Hypoxia induces adipogenic differentitation of myoblastic cell lines. Biochem Biophys Res Commun 399: 721-726, 2010.
80. Jazwa A, Stepniewski J, Zamykal M, Jagodzinska J, Meloni M, Emanueli C, Jozkowicz A, and Dulak J. Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice. Cardiovasc Res 97: 115-124, 2013.
81. Jensen ED, Gopalakrishnan R, and Westendorf JJ. Regulation of gene expression in osteoblasts. Biofactors 36: 25-32, 2010.
82. Jiang YB, Zhang XL, Tang YL, Ma GS, Shen CX, Wei Q, Zhu Q, Yao YY, and Liu NF. Effects of heme oxygenase-1 gene modulated mesenchymal stem cells on vasculogenesis in ischemic swine hearts. Chin Med J (Engl) 124: 401-407, 2011.
83. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, and Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120: 623-634, 2005.
84. Jozkowicz A and Dulak J. Effects of protoporphyrins on production of nitric oxide and expression of vascular en-dothelial growth factor in vascular smooth muscle cells and macrophages. Acta Biochim Pol 50: 69-79, 2003.
85. Kapinas K and Delany AM. MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther 13: 220, 2011.
86. Kapinas K, Kessler CB, and Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 108: 216-224, 2009.
87. Kartikasari AE, Wagener FA, Yachie A, Wiegerinck ET, Kemna EH, and Swinkels DW. Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency. J Cell Mol Med 13: 3091-3102, 2009.
88. Kearns-Jonker M, Dai W, Gunthart M, Fuentes T, Yeh HY, Gerczuk P, Pera M, Mummery C, and Kloner RA. Genetically engineered mesenchymal stem cells influence gene expression in donor cardiomyocytes and the recipient heart. J Stem Cell Res Ther S1, pii: 005, 2012.
89. Kennell JA, Gerin I, MacDougald OA, and Cadigan KM. The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci USA 105: 15417-15422, 2008.
90. Kie JH, Kapturczak MH, Traylor A, Agarwal A, and Hill-Kapturczak N. Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol 19: 1681-1691, 2008.
91. Kim DH, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA, Puri N, and Abraham NG. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J Pharmacol Exp Ther 325: 833-840, 2008.
92. Kim DH, Liu J, Bhat S, Benedict G, Lecka-Czernik B, Peterson SJ, Ebraheim NA, and Heck BE. Peroxisome proliferator-activated receptor delta agonist attenuates nicotine suppression effect on human mesenchymal stem cell-derived osteogenesis and involves increased expression of heme oxygenase-1. J Bone Miner Metab 31: 44-52, 2012.
93. Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, Koduru SR, Zeldin DC, Falck JR, Schwartzman ML, and Abraham NG. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma. Stem Cells Dev 19: 1863-1873, 2010.
94. Kim EK, Lim S, Park JM, Seo JK, Kim JH, Kim KT, Ryu SH, and Suh PG. Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase. J Cell Physiol 227: 1680-1687, 2012.
95. Kim HK, Lee YS, Sivaprasad U, Malhotra A, and Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174: 677-687, 2006.
96. Kim HR, Kim S, Kim EJ, Park JH, Yang SH, Jeong ET, Park C, Youn MJ, So HS, and Park R. Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. Lung Cancer 60: 47-56, 2008.
97. Kim KM, Park SJ, Jung SH, Kim EJ, Jogeswar G, Ajita J, Rhee Y, Kim CH, and Lim SK. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and ske-letogenesis through targeting FoxO1. J Bone Miner Res 27: 1669-1679, 2012.
98. Kim SH, Kim KH, Yoo BC, and Ku JL. Induction of LGR5 by H2O2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells. Int J Oncol 41: 1744-1750, 2012.
99. Kim SJ, Min KS, Ryu HW, Lee HJ, and Kim EC. The role of heme oxygenase-1 in the proliferation and odontoblastic differentiation of human dental pulp cells. J Endod 36: 1326-1331, 2010.
100. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, and Dalla-Favera R. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lym-phocytic leukemia. Cancer Cell 17: 28-40, 2010.
101. Kongpetch S, Kukongviriyapan V, Prawan A, Senggunprai L, Kukongviriyapan U, and Buranrat B. Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. PLoS One 7: e34994, 2012.
102. Kook YA, Lee SK, Son DH, Kim Y, Kang KH, Cho JH, Kim SC, Kim YS, Lee HJ, Lee SK, and Kim EC. Effects of substance P on osteoblastic differentiation and heme oxyge-nase-1 in human periodontal ligament cells. Cell Biol Int 33: 424-428, 2009.
103. Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, and Jozkowicz A. Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid Redox Signal 16: 113-127, 2012.
104. Kreiser D, Nguyen X, Wong R, Seidman D, Stevenson D, Quan S, Abraham N, and Dennery PA. Heme oxygenase-1 modulates fetal growth in the rat. Lab Invest 82: 687-692, 2002.
105. Krishnan V, Bryant HU, and Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209, 2006.
106. Kuang S, Gillespie MA, and Rudnicki MA. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2: 22-31, 2008.
107. Kuang S and Rudnicki MA. The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14: 82-91, 2008.
108. Kuang W, Tan J, Duan Y, Duan J, Wang W, Jin F, Jin Z, Yuan X, and Liu Y. Cyclic stretch induced miR-146a up-regulation delays C2C12 myogenic differentiation through inhibition of Numb. Biochem Biophys Res Commun 378: 259-263, 2009.
109. Kumar R, Halder P, Sahu SK, Kumar M, Kumari M, Jana K, Ghosh Z, Sharma P, Kundu M, and Basu J. Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with Mycobacterium tuberculosis. Cell Microbiol 14: 1620-1631, 2012.
110. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, and Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134: 2895-2902, 2007.
111. Lakkisto P, Kyto V, Forsten H, Siren JM, Segersvard H, Voipio-Pulkki LM, Laine M, Pulkki K, and Tikkanen I. Heme oxygenase-1 and carbon monoxide promote neo-vascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B. Eur J Pharmacol 635: 156-164, 2010.
112. Laumonier T, Yang S, Konig S, Chauveau C, Anegon I, Hoffmeyer P, and Menetrey J. Lentivirus mediated HO-1 gene transfer enhances myogenic precursor cell survival after autologous transplantation in pig. Mol Ther 16: 404-410, 2008.
113. Lee H, Lee YJ, Choi H, Ko EH, and Kim JW. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J Biol Chem 284: 10601-10609, 2009.
114. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, and Lee SY. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106: 852-859, 2005.
115. Lee SJ, Lee EJ, Kim SH, Choi I, Lee DM, Lee HJ, Yoon D, and Chun T. IL-17A promotes transdifferentiation of mouse myoblast cells (C2C12) into adipocytes by increasing the expression of peroxisome proliferator-activated receptor gamma through CAAT/enhancer binding protein beta signaling. Biotechnol Lett 33: 229-235, 2011.
116. Lee SK, Lee CY, Kook YA, Lee SK, and Kim EC. Mechanical stress promotes odontoblastic differentiation via the heme oxygenase-1 pathway in human dental pulp cell line. Life Sci 86: 107-114, 2010.
117. Lee TC and Ho IC. Expression of heme oxygenase in arsenic-resistant human lung adenocarcinoma cells. Cancer Res 54: 1660-1664, 1994.
118. Lee YH, Lee NH, Bhattarai G, Kim GE, Lee IK, Yun BS, Hwang PH, and Yi HK. Anti-inflammatory effect of pa-chymic acid promotes odontoblastic differentiation via HO-1 in dental pulp cells. Oral Dis 19: 193-199, 2012.
119. Lefebvre V and Bhattaram P. Vertebrate skeletogenesis. Curr Top Dev Biol 90: 291-317, 2010.
120. Li L, Julien B, Grenard P, Teixeira-Clerc F, Mallat A, and Lotersztajn S. Molecular mechanisms regulating the anti-fibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. J Hepatol 41: 407-413, 2004.
121. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Ro-della LF, Aronow WS, Ikehara S, and Abraham NG. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57: 1526-1535, 2008.
122. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, and Lian JB. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 284: 15676-15684, 2009.
123. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, and Stein GS. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 105: 13906-13911, 2008.
124. Li Volti G, Ientile R, Abraham NG, Vanella A, Cannavo G, Mazza F, Curro M, Raciti G, Avola R, and Campisi A. Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell cultures during differentiation: effect of glutamate. Biochem Biophys Res Com-mun 315: 517-524, 2004.
125. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Mon-tecino M, Hassan MQ, Gaur T, Lengner CJ, and Young DW. Networks and hubs for the transcriptional control of os-teoblastogenesis. Rev Endocr Metab Disord 7: 1-16, 2006.
126. Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, Aslam M, Fernandez-Gonzalez A, Liu X, Baveja R, and Kourembanas S. Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells 29: 99-107, 2011.
127. Lichner Z, Pall E, Kerekes A, Pallinger E, Maraghechi P, Bosze Z, and Gocza E. The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells. Differentiation 81: 11-24, 2011.
128. Lin CY, Peng CY, Huang TT, Wu ML, Lai YL, Peng DH, Chen PF, Chen HF, Yen BL, Wu KK, and Yet SF. Exacerbation of oxidative stress-induced cell death and differentiation in induced pluripotent stem cells lacking heme oxygenase-1. Stem Cells Dev 21: 1675-1687, 2012.
129. Lin HH, Chen YH, Yet SF, and Chau LY. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemost 7: 1401-1408, 2009.
130. Lin Q, Weis S, Yang G, Weng YH, Helston R, Rish K, Smith A, Bordner J, Polte T, Gaunitz F, and Dennery PA. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem 282: 20621-20633, 2007.
131. Lin TC, Yen JM, Gong KB, Hsu TT, and Chen LR. IGF-1/IGFBP-1 increases blastocyst formation and total blasto-cyst cell number in mouse embryo culture and facilitates the establishment of a stem-cell line. BMC Cell Biol 4: 14, 2003.
132. Lin TH, Tang CH, Hung SY, Liu SH, Lin YM, Fu WM, and Yang RS. Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol 222: 757-768, 2010.
133. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, and Dulak J. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 1767-1812, 2008.
134. Loboda A, Was H, Jozkowicz A, and Dulak J. Janus face of Nrf2-HO-1 axis in cancer-friend in chemoprevention, foe in anticancer therapy. Lung Cancer 60: 1-3, 2008.
135. Lowe CE, O'Rahilly S, and Rochford JJ. Adipogenesis at a glance. J Cell Sci 124: 2681-2686, 2011.
136. Mallanna SK and Rizzino A. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev Biol 344: 16-25, 2010.
137. Marie PJ. Transcription factors controlling osteoblastogen-esis. Arch Biochem Biophys 473: 98-105, 2008.
138. Martin-Puig S, Fuster V, and Torres M. Heart repair: from natural mechanisms of cardiomyocyte production to the design of new cardiac therapies. Ann N Y Acad Sci 1254: 71-81, 2012.
139. Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, Printz D, Fritsch G, Wagner O, Selzer E, Sperr WR, Valent P, and Sillaber C. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res 64: 3148-3154, 2004.
140. Mayerhofer M, Gleixner KV, Mayerhofer J, Hoermann G, Jaeger E, Aichberger KJ, Ott RG, Greish K, Nakamura H, Derdak S, Samorapoompichit P, Pickl WF, Sexl V, Es-terbauer H, Schwarzinger I, Sillaber C, Maeda H, and Va-lent P. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 111: 2200-2210, 2008.
141. McCaig D and Lyall F. Heme oxygenase expression in human placental villous tissue in response to exposure to in vitro ischemia-reperfusion injury. Hypertens Pregnancy 28: 256-272, 2009.
142. McCaig D and Lyall F. Inhibitors of heme oxygenase reduce invasion of human primary cytotrophoblast cells in vitro. Placenta 30: 536-538, 2009.
143. McGregor RA and Choi MS. microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11: 304-316, 2011.
144. Megias J, Guillen MI, Clerigues V, Rojo AI, Cuadrado A, Castejon MA, Gomar F, and Alcaraz MJ. Heme oxygenase-1 induction modulates microsomal prosta-glandin E synthase-1 expression and prostaglandin E(2) production in osteoarthritic chondrocytes. Biochem Pharmacol 77: 1806-1813, 2009.
145. Melton C, Judson RL, and Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463: 621-626, 2010.
146. Merchant AA, Singh A, Matsui W, and Biswal S. The re-dox-sensitive transcription factor Nrf2 regulates murine hematopoietic stem cell survival independently of ROS levels. Blood 118: 6572-6579, 2011.
147. Min KS, Lee YM, Hong SO, and Kim EC. Simvastatin promotes odontoblastic differentiation and expression of angiogenic factors via heme oxygenase-1 in primary cultured human dental pulp cells. J Endod 36: 447-452, 2010.
148. Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, Nakamura T, Kato S, Miyasaka N, Ezura Y, and Noda M. Osteoclast-specific Dicer gene deficiency suppresses osteo-clastic bone resorption. J Cell Biochem 109: 866-875, 2010.
149. Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kanesaki Y, Suda T, Fukuda T, Katagiri T, Kondoh Y, Amemiya T, Tashiro H, and Okazaki Y. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 583: 2263-2268, 2009.
150. Motohashi H, Kimura M, Fujita R, Inoue A, Pan X, Takayama M, Katsuoka F, Aburatani H, Bresnick EH, and Yamamoto M. NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood 115: 677-686, 2010.
151. Mounier R, Chretien F, and Chazaud B. Blood vessels and the satellite cell niche. Curr Top Dev Biol 96: 121-138, 2010.
152. Murchison EP, Partridge JF, Tam OH, Cheloufi S, and Hannon GJ. Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 102: 12135-12140, 2005.
153. Na J, Furue MK, and Andrews PW. Inhibition of ERK1/2 prevents neural and mesendodermal differentiation and promotes human embryonic stem cell self-renewal. Stem Cell Res 5: 157-169, 2010.
154. Nakamura H, Fang J, Gahininath B, Tsukigawa K, and Maeda H. Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP
155. Nakasa T, Shibuya H, Nagata Y, Niimoto T, and Ochi M. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 63: 1582-1590, 2011.
156. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, Gastaldelli A, Rezzani R, Rodella LF, Drummond G, Kusmic C, L'Abbate A, Kappas A, and Abraham NG. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 53: 508-515, 2009.
157. Nowak W, Borys S, Kusinska K, Bukowaska-Strakova K, Witek P, Koblik T, Jozkowicz A, Malecki M, and Dulak J. Number of circulating pro-angiogenic cells, growth factor and antioxidative gene profiles may be altered in type 2 diabetes with and without diabetic foot syndrome. J Diabetes Invest 2013 [Epub ahead of print]; DOI: 10.111/jdi.12131.
158. Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Was H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, and Golab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 25: 3365-3374, 2006.
159. O'Brien JJ, Baglole CJ, Garcia-Bates TM, Blumberg N, Francis CW, and Phipps RP. 15-Deoxy-delta12, 14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis. J Thromb Haemost 7: 182-189, 2009.
160. O'Connell RM and Baltimore D. MicroRNAs and hemato-poietic cell development. Curr Top Dev Biol 99: 145-174, 2012.
161. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Ta-ganov KD, Nicoll J, Paquette RL, and Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205: 585-594, 2008.
162. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, and Harfe BD. Essential role for Dicer during skeletal muscle development. Dev Biol 311: 359-368, 2007.
163. Odemis V, Boosmann K, Dieterlen MT, and Engele J. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta. J Cell Sci 120: 4050-4059, 2007.
164. Okita K and Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci 366: 2198-2207, 2011.
165. Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK, Prockop DJ, and Pochampally R. Human multipotent stromal cells from bone marrow and micro-RNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci USA 105: 18372-18377, 2008.
166. Parise G, O'Reilly CE, and Rudnicki MA. Molecular regulation of myogenic progenitor populations. Appl Physiol Nutr Metab 31: 773-781, 2006.
167. Park HJ, Chung BY, Lee MK, Song Y, Lee SS, Chu GM, Kang SN, Song YM, Kim GS, and Cho JH. Centipede grass exerts anti-adipogenic activity through inhibition of C/EBPbeta, C/EBPalpha, and PPARgamma expression and the AKT signaling pathway in 3T3-L1 adipocytes. BMC Complement Altern Med 12: 230, 2012.
168. Pilegaard H, Ordway GA, Saltin B, and Neufer PD. Tran-scriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol En-docrinol Metab 279: E806-E814, 2000.
169. Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, Chen J, Rowley JD, and Zeleznik-Le NJ. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113: 3314-3322, 2009.
170. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94: 10925-10930, 1997.
171. Pulkkinen KH, Yla-Herttuala S, and Levonen AL. Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic Biol Med 51: 2124-2131, 2011.
172. Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, and Meng S. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 398: 771-777, 2010.
173. Relaix F and Zammit PS. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139: 2845-2856, 2012.
174. Reya T, Morrison SJ, Clarke MF, and Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
175. Romao JM, Jin W, Dodson MV, Hausman GJ, Moore SS, and Guan LL. MicroRNA regulation in mammalian adi-pogenesis. Exp Biol Med (Maywood) 236: 997-1004, 2011.
176. Rushworth SA, Bowles KM, Raninga P, and MacEwan DJ. NF-kappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction. Cancer Res 70: 2973-2983, 2010.
177. Rushworth SA and MacEwan DJ. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood 111: 3793-3801, 2008.
178. Ryter SW, Alam J, and Choi AM. Heme oxygenase-1/car-bon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006.
179. Sakai E, Shimada-Sugawara M, Nishishita K, Fukuma Y, Naito M, Okamoto K, Nakayama K, and Tsukuba T. Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis. J Cell Biochem 113: 486-498, 2012.
180. Sakamoto H, Sakai E, Fumimoto R, Yamaguchi Y, Fukuma Y, Nishishita K, Okamoto K, and Tsukuba T. Deltamethrin inhibits osteoclast differentiation via regulation of heme oxygenase-1 and NFATc1. Toxicol In Vitro 26: 817-822, 2012.
181. Santos DM, Santos MM, Moreira R, Sola S, and Rodrigues CM. Synthetic condensed 1, 4-naphthoquinone derivative shifts neural stem cell differentiation by regulating redox state. Mol Neurobiol 47: 313-324, 2013.
182. Saxena S, Shukla D, Saxena S, Khan YA, Singh M, Bansal A, Sairam M, and Jain SK. Hypoxia preconditioning by cobalt chloride enhances endurance performance and protects skeletal muscles from exercise-induced oxidative damage in rats. Acta Physiol (Oxf) 200: 249-263, 2010.
183. Schipper HM, Song W, Zukor H, Hascalovici JR, and Zeligman D. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110: 469-485, 2009.
184. Schneider KS and Chan JY. Emerging role of nrf2 in adi-pocytes and adipose biology. Adv Nutr 4: 62-66, 2013.
185. Shin DH, Park HM, Jung KA, Choi HG, Kim JA, Kim DD, Kim SG, Kang KW, Ku SK, Kensler TW, and Kwak MK. The NRF2-heme oxygenase-1 system modulates cyclos-porin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic Biol Med 48: 1051-1063, 2010.
186. Shu T, Zeng B, Ren X, and Li Y. HO-1 modified mesen-chymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium. Tissue Cell 42: 217-222, 2010.
187. Siminovitch L, McCulloch EA, and Till JE. The distribution of colony-forming cells among spleen colonies. J Cell Physiol 62: 327-336, 1963.
188. Singh MM, Irwin ME, Gao Y, Ban K, Shi P, Arlinghaus RB, Amin HM, and Chandra J. Inhibition of the NADPH oxi-dase regulates heme oxygenase 1 expression in chronic myeloid leukemia. Cancer 118: 3433-3445, 2012.
189. Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, Gil T, Kuzdzal J, Muchova L, Vitek L, Loboda A, Joz-kowicz A, Kieda C, and Dulak J. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization and metastasis. Antioxid Redox Signal 19: 644-660, 2013.
190. So AY, Garcia-Flores Y, Minisandram A, Martin A, Taga-nov K, Boldin M, and Baltimore D. Regulation of APC development, immune response, and autoimmunity by Bach1/HO-1 pathway in mice. Blood 120: 2428-2437, 2012.
191. Sodhi K, Inoue K, Gotlinger KH, Canestraro M, Vanella L, Kim DH, Manthati VL, Koduru SR, Falck JR, Schwartzman ML, and Abraham NG. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 331: 906-916, 2009.
192. Sodhi K, Puri N, Inoue K, Falck JR, Schwartzman ML, and Abraham NG. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat 98: 133-142, 2012.
193. Sohni A and Verfaillie CM. Multipotent adult progenitor cells. Best Pract Res Clin Haematol 24: 3-11, 2011.
194. Sokol NS. The role of microRNAs in muscle development. Curr Top Dev Biol 99: 59-78, 2012.
195. Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, and Loboda A. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochra-toxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res 57: 504-515, 2013.
196. Starczynowski DT, Kuchenbauer F, Wegrzyn J, Rouhi A, Petriv O, Hansen CL, Humphries RK, and Karsan A. Mi-croRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol 39: 167-178 e4, 2011.
197. Stavridis MP, Lunn JS, Collins BJ, and Storey KG. A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 134: 2889-2894, 2007.
198. Stefani G and Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230, 2008.
199. Suda T, Takubo K, and Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9: 298-310, 2011.
200. Sugatani T and Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 284: 4667-4678, 2009.
201. Suh GY, Jin Y, Yi AK, Wang XM, and Choi AM. CCAAT/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2. Am J Respir Cell Mol Biol 35: 220-226, 2006.
202. Takada I, Kouzmenko AP, and Kato S. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opin Ther Targets 13: 593-603, 2009.
203. Takada I, Kouzmenko AP, and Kato S. Wnt and PPAR-gamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5: 442-447, 2009.
204. Tang QQ and Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 81: 715-736, 2012.
205. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, and Phillips MI. Improved graft mesenchymal stem cell survival in is-chemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350, 2005.
206. Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, Lillington D, Oakervee H, Cavenagh J, Agrawal SG, Lister TA, Gribben JG, and Bonnet D. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112: 568-575, 2008.
207. Teitelbaum SL and Ross FP. Genetic regulation of osteo-clast development and function. Nat Rev Genet 4: 638-649, 2003.
208. Thomas ED, Lochte HL, Jr., Cannon JH, Sahler OD, and Ferrebee JW. Supralethal whole body irradiation and iso-logous marrow transplantation in man. J Clin Invest 38: 1709-1716, 1959.
209. Till JE and Mc CE. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14: 213-222, 1961.
210. Tong AW and Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355, 2008.
211. Toobiak S, Shaklai M, and Shaklai N. Carbon monoxide induced erythroid differentiation of K562 cells mimics the central macrophage milieu in erythroblastic islands. PLoS One 7: e33940, 2012.
212. Townley-Tilson WH, Callis TE, and Wang D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 42: 1252-1255, 2010.
213. Treiber T, Treiber N, and Meister G. Regulation of micro-RNA biogenesis and function. Thromb Haemost 107: 605-610, 2012.
214. Trigona WL, Porter CM, Horvath-Arcidiacono JA, Ma-jumdar AS, and Bloom ET. Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid Redox Signal 9: 751-756, 2007.
215. Tsai JJ, Dudakov JA, Takahashi K, Shieh JH, Velardi E, Holland AM, Singer NV, West ML, Smith OM, Young LF, Shono Y, Ghosh A, Hanash AM, Tran HT, Moore MA, and van den Brink MR. Nrf2 regulates haematopoietic stem cell function. Nat Cell Biol 15: 309-316, 2013.
216. Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri MA, Ishibashi-Ueda H, Nagaya N, and Yamagishi M. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxyge-nase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol 298: H1320-H1329, 2010.
217. Valencia-Sanchez MA, Liu J, Hannon GJ, and Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524, 2006.
218. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ, Jr., and Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662-673, 2009.
219. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, and Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579, 2007.
220. van Tienen FH, Laeremans H, van der Kallen CJ, and Smeets HJ. Wnt5b stimulates adipogenesis by activating PPARgamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a. Biochem Bio-phys Res Commun 387: 207-211, 2009.
221. Vanella L, Kim DH, Asprinio D, Peterson SJ, Barbagallo I, Vanella A, Goldstein D, Ikehara S, Kappas A, and Abraham NG. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 46: 236-243, 2010.
222. Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Falck JR, Schwartzman ML, and Abraham NG. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat 96: 54-62, 2011.
223. Wang LD and Wagers AJ. Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol 12: 643-655, 2011.
224. Wang Y, Medvid R, Melton C, Jaenisch R, and Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39: 380-385, 2007.
225. Watanabe-Matsui M, Muto A, Matsui T, Itoh-Nakadai A, Nakajima O, Murayama K, Yamamoto M, Ikeda-Saito M, and Igarashi K. Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood 117: 5438-5448, 2011.
226. Watanabe S, Akagi R, Mori M, Tsuchiya T, and Sassa S. Marked developmental changes in heme oxygenase-1 (HO-1) expression in the mouse placenta: correlation between HO-1 expression and placental development. Placenta 25: 387-395, 2004.
227. Watanabe T, Hasegawa G, Yamamoto T, Hatakeyama K, Suematsu M, and Naito M. Expression of heme oxygenase-1 in rat ontogeny. Arch Histol Cytol 66: 155-162, 2003.
228. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287: 1442-1446, 2000.
229. Weng JJ and Su Y. Nuclear matrix-targeting of the osteo-genic factor Runx2 is essential for its recognition and activation of the alkaline phosphatase gene. Biochim Biophys Acta 1830, 2839-2852, 2012.
230. Wong RJ, Zhao H, and Stevenson DK. A deficiency in haem oxygenase-1 induces foetal growth restriction by placental vasculature defects. Acta Paediatr 101: 827-834, 2012.
231. Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, Chan K, Hassenpflug J, Freitag-Wolf S, Varoga D, Lippross S, and Pufe T. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 70: 844-850, 2011.
232. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, Gamble JR, and Stocker R. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29: 1537-1542, 2009.
233. Xia Z, Chen C, Chen P, Xie H, and Luo X. MicroRNAs and their roles in osteoclast differentiation. Front Med 5: 414-419, 2011.
234. Xia ZW, Zhong WW, Meyrowitz JS, and Zhang ZL. The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzyme. Curr Pharm Des 14: 454-464, 2008.
235. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, and Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658, 2009.
236. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
237. Yamaguchi Y, Sakai E, Sakamoto H, Fumimoto R, Fukuma Y, Nishishita K, Okamoto K, and Tsukuba T. Inhibitory effects of tert-butylhydroquinone on osteoclast differentiation via up-regulation of heme oxygenase-1 and down-regulation of HMGB1 release and NFATc1 expression. J Appl Toxicol [Epub ahead of print]; DOI: 10.1002/jat.2827, 2012.
238. Yeom KH, Lee Y, Han J, Suh MR, and Kim VN. Characterization of DGCR8/Pasha, the essential cofactor for Drosha in primary miRNA processing. Nucleic Acids Res 34: 4622-4629, 2006.
239. Yoder MC. Endothelial progenitor cell: a blood cell by many other names may serve similar functions. J Mol Med (Berl) 91: 285-295, 2013.
240. Yoon JS, Lee HJ, Chae MK, Lee SY, and Lee EJ. Cigarette-smoke-extract- induced adipogenesis in Graves' orbital fi-broblasts is inhibited by quercetin via reduction in oxida-tive stress. J Endocrinol 216, 145-165, 2013.
241. Younce C and Kolattukudy P. MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy. Cell Physiol Biochem 30: 307-320, 2012.
242. Zarjou A, Jeney V, Arosio P, Poli M, Antal-Szalmas P, Agarwal A, Balla G, and Balla J. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol 20: 1254-1263, 2009.
243. Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, Agarwal A, and Curtis LM. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxyge-nase-1. Am J Physiol Renal Physiol 300: F254-F262, 2011.
244. Zenclussen AC, Sollwedel A, Bertoja AZ, Gerlof K, Zen-clussen ML, Woiciechowsky C, and Volk HD. Heme oxy-genase as a therapeutic target in immunological pregnancy complications. Int Immunopharmacol 5: 41-51, 2005.
245. Zenclussen ML, Anegon I, Bertoja AZ, Chauveau C, Vogt K, Gerlof K, Sollwedel A, Volk HD, Ritter T, and Zenclussen AC. Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. J Reprod Immunol 69: 35-52, 2006.
246. Zeng B, Chen H, Zhu C, Ren X, Lin G, and Cao F. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac Surg 34: 850-856, 2008.
247. Zhang Z, Wang Q, Ma J, Yi X, Zhu Y, Xi X, Feng Y, and Jin Z. Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1alpha signaling in human epithelial ovarian cancer. Oncol Rep 29: 1429-1434, 2013.
248. Zhao F, Wu T, Lau A, Jiang T, Huang Z, Wang XJ, Chen W, Wong PK, and Zhang DD. Nrf2 promotes neuronal cell differentiation. Free Radic Biol Med 47: 867-879, 2009.
249. Zhao H, Kalota A, Jin S, and Gewirtz AM. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood 113: 505-516, 2009.
250. Zhao H, Wong RJ, Doyle TC, Nayak N, Vreman HJ, Contag CH, and Stevenson DK. Regulation of maternal and fetal hemodynamics by heme oxygenase in mice. Biol Reprod 78: 744-751, 2008.
251. Zhao H, Wong RJ, Kalish FS, Nayak NR, and Stevenson DK. Effect of heme oxygenase-1 deficiency on placental development. Placenta 30: 861-868, 2009.
252. Zhao Q, Wang X, Liu Y, He A, and Jia R. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol 42: 576-579, 2010.
253. Zhou H, Ramiya VK, and Visner GA. Bone marrow stem cells as a vehicle for delivery of heme oxygenase-1 gene. Stem Cells Dev 15: 79-86, 2006.
254. Zhou Z, Han JY, Xi CX, Xie JX, Feng X, Wang CY, Mei L, and Xiong WC. HMGB1 regulates RANKL-induced osteo-clastogenesis in a manner dependent on RAGE. J Bone Miner Res 23: 1084-1096, 2008.
255. Zhu W, Boachie-Adjei O, Rawlins BA, Frenkel B, Boskey AL, Ivashkiv LB, and Blobel CP. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem 282: 18676-18685, 2007.
256. Zwerina J, Tzima S, Hayer S, Redlich K, Hoffmann O, Hanslik-Schnabel B, Smolen JS, Kollias G, and Schett G. Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. Faseb J 19: 2011-2013, 2005.